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INTRODUCTION
Growth factors such as transforming
growth factor-β (TGF-β), vascular endo-
thelial growth factor (VEGF), insulin-like
growth factor-1 (IGF-1), platelet-derived
growth factor (PDGF), and basic fibroblast
growth factor (bFGF) have been associated
with the tendon healing process (Molloy
et al., 2003; Zhang et al., 2003; Halper,
2014). Among these growth factors, TGF-
β1 plays a key role during the various tissue
repair stages and is secreted not only by
fibroblasts differentiated from mesenchy-
mal stem cells (MSCs), but also by sev-
eral types of cells that differentiate from
hematopoietic stem cells (HSCs; Sporn
et al., 1986).
In this review, the role of TGF-β
and MSC-derived fibroblasts in tendon
and ligament tissue repair is described.
Furthermore, the potential application of
bonemarrow cell transplantation (BMCT)
as a novel method for treating tendon and
ligament injuries is also discussed.
HEALING PROCESS
Human tendon healing process is classi-
fied into five phases as follows: immedi-
ate post injury phase, inflammatory phase,
proliferation phase, reparative phase, and
remodeling phase (Molloy et al., 2003).
Tissue repair depends on both intrin-
sic and extrinsic processes. Intrinsic heal-
ing occurs within the tendon itself as a
result of the activity of intrinsic fibrob-
lasts and an increased intratendinous
blood supply from the synovium and
osseous insertion (Deie et al., 1995; Koga
et al., 2007). Extrinsic factors that influ-
ence tissue repair include the availability
of proteins originating from peripheral
fibroblasts, plasma, inflammatory cells,
and extratendinous vascular invasion (Lee
et al., 1998; Zhang et al., 2003).
FIBLOBLASTS AND COLLAGEN FIBERS
IN TISSUE REPAIR
During the inflammatory phase, fibrob-
lasts located within the tendon proliferate
and circulatory fibroblasts migrate into the
injured tissue site. The fibroblasts then
synthesize new extracellular matrix pro-
teins that predominantly consist of col-
lagens and glycosaminoglycans (Molloy
et al., 2003). The tendon is primarily made
up of type-I collagen along with small
amounts of other collagens such as type-
III collagen. Type-I collagen is a mature
form of collagen and is mainly responsible
for the mechanical strength of the ten-
don. On the other hand, type-III collagen,
which is thinner and more extensible than
type-I collagen, is not a major collagen in
normal tendon. However, type-III collagen
is required during the earliest stage of ten-
don healing because it can rapidly cross
link and stabilize the precarious repair site
(Liu et al., 1995; Eriksen et al., 2002).
GROWTH FACTORS
As mentioned previously, growth factors
are essential during the various stages of
the tendon healing process (Molloy et al.,
2003; Zhang et al., 2003; Halper, 2014).
Among these growth factors, TGF-β and
VEGF are important for initiating tissue
repair (Molloy et al., 2003; Mienaltowski
and Birk, 2014). Furthermore, TGF-β
can enhance the production of VEGF
(Anitua et al., 2005; Wang et al., 2005,
2008). TGF-β regulates various biological
processes including cell proliferation,
migration, differentiation, apoptosis, and
extracellular matrix deposition (Molloy
et al., 2003). In particular, TGF-β1 acceler-
ates the proliferation and matrix synthesis
of ligament fibroblasts (Schmidt et al.,
1995; Marui et al., 1997; Scherping et al.,
1997). In addition, TGF-β modulates pro-
teoglycan deposition and stimulates the
production of collagens by fibroblasts (Fu
et al., 2005).
VEGF is also a powerful stimulator
of angiogenesis and is especially impor-
tant during the proliferative and remod-
eling phases (Molloy et al., 2003). Zhang
et al. reported that the injection of exoge-
nous VEGF in the injured site can signif-
icantly improve tensile strength of the rat
Achilles tendon by stimulating growth fac-
tor production, which improves fibroblast
proliferation (Zhang et al., 2003).
ROLE OF BONE MARROW CELLS IN
TISSUE REPAIR
Recently, platelet-rich therapies that
use a multitude of growth factors have
been reported to good clinical outcomes
for soft tissue injuries (Moraes et al.,
2014). However, Kiapour et al stated in
their review that the platelet-rich ther-
apies have challenges associated with
the short life span of these bio-active
agents and the limited treatment efficacy.
Furthermore. Kiapour et al stated that
platelet-rich therapies required safe and
reproducible systems that allow sustained
delivery of growth factors to the injury
site are essential (Kiapour and Murray,
2014).
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Bone marrow cells (BMCs) consist
of MSCs and HSCs, which can further
differentiate into various cell types that
secrete growth factors (Sporn et al., 1986;
Baylink et al., 1993). For example, HSCs
have the capacity to differentiate into
growth-factor-secreting hematolymphoid
cells such as lymphocytes, macrophages,
granulocytes, eosinophils, erythroblasts,
erythrocytes, and megakaryocytes and
these cells secrete tissue repair cytokines
such as TGF-β1 (Sporn et al., 1986). On
the other hand, MSCs have the capac-
ity to differentiate into several types
of cells including osteocytes, chondro-
cytes, myotubes, stromal cells, fibrob-
lasts, and adipocytes (Caplan, 2009; Wang
et al., 2013). In particular, inflammatory
cytokines such as IL-1β induce differentia-
tion ofMSCs into osteoblasts and promote
mineralizing of soft tissues (Ferreira et al.,
2013). MSCs themselves produce growth
factors and anti-inflammatory cytokines
(Le Blanc and Ringdén, 2006; Wang et al.,
2008). Furthermore, MSCs differentiate
into cells that participate in tissue repair
and secrete growth factors and cytokines
(Zantop et al., 2006; Chong et al., 2007; Ju
et al., 2008). Undifferentiated MSCs pro-
duce growth factors and cytokines that
promote the expansion and differentia-
tion of HSCs and modify the response of
inflammatory immune cells (Le Blanc and
Ringdén, 2006).
BMCT FOR TREATING TENDON
RUPTURE
The effectiveness of MSC transplantation
is due to the differentiation of MSCs into
cells that participate in tissue repair and
also due to the release of paracrine fac-
tors such as growth factors and cytokines
by the transplanted cells (Wang et al.,
2008). Previous studies show that inject-
ing MSCs at injury sites can accelerate
Achilles tendon healing in animal mod-
els (Zantop et al., 2006; Chong et al.,
2007; Hou et al., 2009). Chong et al have
reported that bone marrow-derived MSCs
influence early tendon healing in rabbits
(Chong et al., 2007). Zantop et al have
reported that extracellular matrix scaffolds
are repopulated by bone marrow-derived
cells in a mouse model of Achilles ten-
don reconstruction (Zantop et al., 2006).
Hou et al. have characterized the effects
of TGF-β1 and VEGF165 gene transfer
on Achilles tendon healing (Hou et al.,
2009).
Recently, we characterized the effects of
injecting whole BMCs, which consist of
both MSCs and HSCs, on tendon healing
in a rat model of Achilles tendon rupture
and evaluated the effects of growth factors
on the early stages of healing (Okamoto
et al., 2010). We showed that the levels of
TGF-β and VEGF in tendons treated with
BMCs were higher than those in tendons
treated withMSCs. Thus, the BMC-treated
group showed a rapid increase in types-I
and III collagen and faster recovery of the
ultimate failure load.
BMCT FOR TREATING ANTERIOR
CURUCIATE LIGANENT PARTIAL
RUPUTURE
Spontaneous regeneration of anterior cru-
ciate ligament (ACL) is impeded by the
lack of soft tissue around it. However,
partially ruptured ACL can regenerate
with growth factor administration and
after cell transplantation. Intra-articular
transplantation therapies usingMSCs have
been used for treating torn ACLs (Agung
et al., 2006; Kanaya et al., 2007). Kanaya
et al showed that the injected MSCs
produced growth factors such as PDGF,
bFGF, and TGF-β, which can activate the
native ACL cells. The authors proposed
that the native ACL cells may have
FIGURE 1 | Mechanisms underlying the treatment of anterior cruciate ligament healing by
intra-articular bone marrow transplantation with fresh whole bone marrow cells. For anterior
cruciate ligament (ACL) healing, fresh whole bone marrow cells (BMCs) that are primarily
comprised of mesenchymal stem cells (MSCs) and hematopoietic stem cells should be preferably
used because the combination has significant advantages over MSCs only. The dotted arrows show
the cascade of events that lead to ACL healing in general. The solid arrows show the effects of
intra-articular bone marrow transplant with fresh whole BMCs. (This figure was taken from Oe
et al., 2011).
proliferated and migrated into the injured
area of the ACL. Furthermore, Agung
et al have characterized the mobilization
of bone marrow-derived MSCs into the
injured tissues after intra-articular injec-
tion and their role in tissue regenera-
tion (Agung et al., 2006). Taken together,
these studies indicate that intra-articular
transplantation therapies usingMSCs have
excellent outcomes for the regeneration of
a transected ACL.
Recently, we showed that partially tran-
sected rodent ACL can be repaired by
injection of BMCs or cultured MSCs
into the articular cavity at 1 week after
transection (Oe et al., 2011). The rat
ACLs of the BMC and MSC groups after
4 weeks of treatment appeared almost
normal histologically, and the tensile
strength of the ACLs of the BMC group
reached near normal levels biomechan-
ically. Furthermore, immunostaining for
type-I collagen showed that the number
of nuclei in the BMC group was signifi-
cantly higher than that in the MSC group
or the saline group. The levels of TGF-β1
in the ACL tissue and knee joint fluid in
the BMC group were significantly higher
than that of the saline group at 4 weeks. In
conclusion, intra-articular bone marrow
transplantation using fresh whole BMCs
is an effective treatment for ACL partial
rupture (Figure 1).
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CONCLUSION AND FUTURURE
PROSPECTS
Stem cell therapies use several stem cell
sources such as human embryonic stem
cells, MSCs, BMCs, and bone marrow
mononucleated cells have been reported
(Chen et al., 2013). Furthermore, trans-
plantation of the genetical transduced
stem cells by “Scleraxis,” which is a tran-
scription factor involving tendon develop-
ment, have been used for effective tendon
regeneration (Gulotta and Rodeo, 2011).
Transplantation of MSCs that are genet-
ically transduced with “Smad8/BMP2,”
which is induced tendon formation and
blocked differentiation of these cells into
cartilage and bone tissues, has been
reported to induce accelerated recovery
of torn Achilles tendon (Pelled et al.,
2012).
Few clinical trials have been per-
formed using stem cells transplantations
for treating tendon and ligament injuries
in humans. Ahmad et al have reviewed 5
clinical studies that used stem cell ther-
apy for treating tendon injuries and con-
cluded that stem cells can have positive
effect on tendon healing (Ahmad et al.,
2012). In this review, we have reviewed
the various processes that influence tis-
sue repair by BMCT, which consist of
both MSC and HSCs. The cells and pro-
cesses involved in tendon healing are as
follows: (1) fibroblasts that differentiate
from MSCs secrete various growth fac-
tors and synthesize type-I collagen, (2)
hematolymphoid cells that differentiate
from HSCs secrete important growth fac-
tors and cytokines for extrinsic healing,
and (3) microenvironments such as vas-
cularization are improved in the dam-
aged portion for tendon and ligament
healing. Overall, BMCT may be more
convenient and easily obtainable than cul-
tured MSCs and can influence tendon and
ligament repair though various healing
processes.
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